Haiwang Group is a large-scale comprehensive enterprise group with pharmaceutical industry and bioengineering as its core. Over the past decades, Haiwang has been based on the frontier of the biopharmaceutical industry, actively promoting scientific and technological innovation, and has continued to develop and grow rapidly in the fields of pharmaceutical industry and bioengineering industry. Haiwang has the most valuable brand in China's pharmaceutical industry, and the trademark "Haiwang" is a well-known trademark in China.

In 2013, Haiwang was awarded the "Top 500 Chinese Brands" award in the "Top 500 Chinese Brands" ranking and publishing activity jointly organized by China Brand Value Research Institute, the Central Committee for National Research and Focus China Network, and was ranked among the "Top 500 Chinese Brands" in the pharmaceutical industry, with its distinctive brand positioning and strong brand competitiveness.